Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS. (Q34522059)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

0 references

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

S Lalezari

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

U Martinowitz

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M M Enriquez

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

H Delesen

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

L Schwartz

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

I Scharrer

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

20 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

e15-22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Clearance mechanisms of von Willebrand factor and factor VIII.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Health-related quality of life as outcome parameter in haemophilia treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Haemophilia prophylaxis in young patients--a long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

The impact of prophyactic treatment on children with severe haemophilia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor antigen levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

7 July 2018

A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Prophylaxis for severe haemophilia: clinical and economical issues

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Cysteine-mutations in von Willebrand factor associated with increased clearance

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FHAE.12294

21 January 2018

Factor VIII half-life and clinical phenotype of severe hemophilia A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

27 October 2018

Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

27 October 2018

Enzyme immunoassay for factor VIII-related antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233978

27 October 2018

Efficacy and safety of prophylaxis with once-weekly BAY 79–4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24252058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A

1 reference

https://pubmed.ncbi.nlm.nih.gov/24252058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Von Willebrand factor in Italian centenarians

1 reference

https://pubmed.ncbi.nlm.nih.gov/24252058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII

1 reference

https://pubmed.ncbi.nlm.nih.gov/24252058

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/HAE.12294

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24252058%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34522059&oldid=1969418262"